Cubist Systematic Strategies, LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$786,216
-62.8%
26,642
-71.0%
0.01%
-61.5%
Q1 2023$2,115,210
+1471.5%
91,806
+1796.8%
0.01%
+1200.0%
Q4 2022$134,600
-88.6%
4,840
-87.4%
0.00%
-85.7%
Q3 2022$1,177,000
-44.4%
38,341
-46.7%
0.01%
-46.2%
Q2 2022$2,116,000
+306.9%
71,904
+344.7%
0.01%
+225.0%
Q1 2022$520,000
+48.1%
16,169
+105.6%
0.00%
+33.3%
Q4 2021$351,000
-27.6%
7,866
-18.1%
0.00%
-50.0%
Q3 2021$485,000
-59.0%
9,606
-36.2%
0.01%
-53.8%
Q2 2021$1,182,000
-75.3%
15,068
-82.0%
0.01%
-78.7%
Q1 2021$4,776,000
+165.8%
83,641
+290.0%
0.06%
+144.0%
Q4 2020$1,797,000
-42.7%
21,449
-75.5%
0.02%
-45.7%
Q3 2020$3,138,000
+530.1%
87,569
+325.3%
0.05%
+411.1%
Q2 2020$498,000
+21.2%
20,590
-12.4%
0.01%
-18.2%
Q1 2020$411,000
-15.1%
23,499
+12.8%
0.01%
-31.2%
Q1 2019$484,000
+163.0%
20,840
+77.0%
0.02%
+60.0%
Q4 2017$184,00011,7750.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders